Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Rubio

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Prostate|February 21, 2020
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening populationJose Rubio-Briones, Angel Borque-Fernando, Luis M Esteban, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Clinical Genitourinary Cancer|May 18, 2022
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC RegistryMargaret F Meagher, Maria C Mir, Riccardo Autorino, et al.
European Urology Oncology|May 17, 2020
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Riccardo Campi, Alessandro Larcher, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
BJU International|April 6, 2026
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) studyJose Rubio-Briones, Félix Guerrero Ramos, Asier Mercadé Sánchez, et al.
Contemporary Clinical Trials|November 8, 2015
Activating brown adipose tissue through exercise (ACTIBATE) in young adults: Rationale, design and methodologyGuillermo Sanchez-Delgado, Borja Martinez-Tellez, Josune Olza, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Journal of Affective Disorders|December 31, 2022
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adultsMarco Solmi, Trevor Thompson, Andrés Estradé, et al.
Psychiatry Research|September 21, 2024
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT StudyMarco Solmi, Trevor Thompson, Andrés Estradé, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Prostate|February 21, 2020
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening populationJose Rubio-Briones, Angel Borque-Fernando, Luis M Esteban, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Clinical Genitourinary Cancer|May 18, 2022
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC RegistryMargaret F Meagher, Maria C Mir, Riccardo Autorino, et al.
European Urology Oncology|May 17, 2020
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Riccardo Campi, Alessandro Larcher, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
BJU International|April 6, 2026
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) studyJose Rubio-Briones, Félix Guerrero Ramos, Asier Mercadé Sánchez, et al.
Contemporary Clinical Trials|November 8, 2015
Activating brown adipose tissue through exercise (ACTIBATE) in young adults: Rationale, design and methodologyGuillermo Sanchez-Delgado, Borja Martinez-Tellez, Josune Olza, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Journal of Affective Disorders|December 31, 2022
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adultsMarco Solmi, Trevor Thompson, Andrés Estradé, et al.
Psychiatry Research|September 21, 2024
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT StudyMarco Solmi, Trevor Thompson, Andrés Estradé, et al.
Pageof 8